![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
K Hosoda, LR Fitzgerald, VA Vaidya, GK Feussner, PH Fishman and RS Duman
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06508, USA.
Incubation of rat C6 glioma cells with beta-adrenergic receptor (beta AR) agonist or with agents that increase cAMP levels results in down- regulation of the beta 2AR, as measured by the loss of radioligand binding sites. In the present study, the role of beta 2AR mRNA expression and stability in the down-regulation of beta 2AR sites in C6 cells was examined. Isoproterenol or forskolin treatment decreased beta 2AR mRNA levels in a time-dependent manner, with maximal loss of approximately 50% being observed after 2 hr. Pretreatment of the cells with a potent protein synthesis inhibitor, Pseudomonas exotoxin A, completely blocked isoproterenol- and forskolin-mediated down- regulation of beta 2AR mRNA. Exposure to agonist did not significantly influence the half-life of beta 2AR mRNA, which was approximately 60 min. In contrast, isoproterenol treatment for 2 hr significantly decreased the rate of beta 2AR gene transcription, as determined by nuclear run-on analysis. Based on these results, we propose that agonist regulation of beta 2AR mRNA in C6 cells is mediated by activation of the cAMP system and occurs at the level of beta 2AR gene transcription, not mRNA stability. In addition, the observed requirement for protein synthesis indicates that down-regulation of beta 2AR mRNA may be mediated by expression of a repressor of beta 2AR gene transcription.
This article has been cited by other articles:
|
|
 |
|
  M. A. Sussman ICER-Capades: Putting Cardiac Cyclic AMP Signaling "On Ice" Circ. Res., July 11, 2003; 93(1): 6 - 8. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kirigiti, Y. Bai, Y.-F. Yang, X. Li, B. Li, G. Brewer, and C. A. Machida Agonist-Mediated Down-Regulation of Rat beta 1-Adrenergic Receptor Transcripts: Role of Potential Post-Transcriptional Degradation Factors Mol. Pharmacol., December 1, 2001; 60(6): 1308 - 1324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. Shishkina, T. S. Kalinina, N. Yu. Sournina, and N. N. Dygalo Effects of Antisense to the {alpha}2A-Adrenoceptors Administered into the Region of the Locus Ceruleus on Behaviors in Plus-Maze and Sexual Behavior Tests in Sham-Operated and Castrated Male Rats J. Neurosci., January 15, 2001; 21(2): 726 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Blaxall, A. C. Pellett, S. C. Wu, A. Pende, and J. D. Port Purification and Characterization of beta -Adrenergic Receptor mRNA-binding Proteins J. Biol. Chem., February 11, 2000; 275(6): 4290 - 4297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Li, V. A. Vaidya, J. D. Alvaro, P. A. Iredale, R. Hsu, G. Hoffman, L. Fitzgerald, P. K. Curran, C. A. Machida, P. H. Fishman, et al. Protein Kinase C-Mediated Down-Regulation of beta 1-Adrenergic Receptor Gene Expression in Rat C6 Glioma Cells Mol. Pharmacol., July 1, 1998; 54(1): 14 - 21. [Abstract] [Full Text]
|
|
|
|
|
|
X. Wang, G. Nickenig, and T. J. Murphy The Vascular Smooth Muscle Type I Angiotensin II Receptor mRNA Is Destabilized by Cyclic AMP-Elevating Agents Mol. Pharmacol., November 1, 1997; 52(5): 781 - 787. [Abstract] [Full Text]
|
|
|
|
 |
|
 D. A. Heck and D. B. Bylund Mechanism of Down-regulation of Alpha-2 Adrenergic Receptor Subtypes J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1219 - 1227. [Abstract] [Full Text]
|
|
|
|
|
|
P. A. Iredale and R. S. Duman Glucocorticoid Regulation of Corticotropin-Releasing Factor1 Receptor Expression in Pituitary-Derived AtT-20 Cells Mol. Pharmacol., May 1, 1997; 51(5): 794 - 799. [Abstract] [Full Text]
|
|
|
|
|
|
F. Souaze, W. Rostene, and P. Forgez Neurotensin Agonist Induces Differential Regulation of Neurotensin Receptor mRNA. IDENTIFICATION OF DISTINCT TRANSCRIPTIONAL AND POST-TRANSCRIPTIONAL MECHANISMS J. Biol. Chem., April 11, 1997; 272(15): 10087 - 10094. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Small, K. M. Brown, S. L. Forbes, and S. B. Liggett Modification of the beta 2-Adrenergic Receptor to Engineer a Receptor-Effector Complex for Gene Therapy J. Biol. Chem., August 17, 2001; 276(34): 31596 - 31601. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
